WECAN, an informal network of leaders of cancer patient umbrella organisations active in Europe, has developed, together with with PFMD and legal experts from 12 pharmaceutical companies, an important set of guiding principles for reasonable legal agreements between patient advocates and pharmaceutical companies.
The guidelines aims to make legal agreements between both parties easier and more acceptable while providing adequate protection and rules for both sides.
The topics are developed in sections concerning:
- intellectual property
- recordings of meetings
- data protection
- personal data
- conflict resolution
- financial compensation
- reimbursement of expenses
- adverse event reporting
- conflict of interest
Each section covers rationale, examples and guiding principles for legal agreements between pharmaceutical companies and patient advocates
These guiding principles are the result of consensus work between patient advocates and pharmaceutical companies’ representatives.
They should provide the guiding baseline for the development of contracts and contract templates as well as a checklist for patient advocates and companies.
Download the full document here: Guiding Principles on Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies